NEWSROOM

Nutraceuticals

PURA Expects To Boost Revenue Entering $17 Billion CBD Nutraceutical Market

Dallas, Texas, March 14, 2022 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) are working together on a new line of CBD Nutraceuticals under PURA’s Farmersville Hemp Brand Name. Later this week, on Thursday, March 17, 2022, the two companies plan to publish a sneak on the coming launch of a new CBD Nutraceutical Line. The CBD Nutraceutical market is anticipated to reach a value over $17 billion by 2026. PURA and PAOG anticipate the new Farmersville...

read more

PURA Confirms Asia Pacific Hemp Partnership Developments And 2022 Revenue Increase Potential

Dallas, Texas, Feb. 23, 2022 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today confirmed the company is on the verge of striking its first partnership opportunity in the Asia Pacific Region. The partnership could result in PURA raising its $10 million stretch revenue target. PURA included details on its initiative to expand its partnership income potential with a new global emphasis in the progress report update on its 2022 strategic plan published yesterday. The entire update can be...

read more

PURA Confirms Farmersville Hemp Strategic Update Scheduled Next Week

Dallas, Texas, Feb. 17, 2022 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today confirmed the company will publish a report next week on the company’s progress to date on the execution of its 2022 strategic plan. The update will be published on Tuesday, February 22nd. PURA anticipates generating at least $1 million in revenue in 2022 with the potential to reach $10 million in revenue. The $10 million revenue opportunity outlook is improving based on the recent progress of PURA’s co-op...

read more

PURA Zeros In On 2022 $10 Million Stretch Revenue Objective

Dallas, Texas, Feb. 15, 2022 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) anticipates generating $1 million in revenue in 2022 with the potential to reach $10 million in revenue this year. The $10 million revenue opportunity outlook is improving based on the recent progress of PURA’s co-op partners. Last year, PURA retooled its years of experience with hemp to take on a much larger opportunity in 2022. PURA has launched an initiative to expand the utilization of hemp worldwide under the...

read more

PURA Highlights Blackrock Climate Change Unicorn Outlook In Light Of Farmersville Hemp Brand

Dallas, Texas, Feb. 09, 2022 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today highlighted Blackrock, Inc. CEO Larry Fink’s recent comments on companies with innovative offerings that can impact climate change. PURA management considers Mr. Fink’s comments as further validation of PURA’s industrial hemp strategy to introduce hemp-based sustainable innovations. From Blackrock CEO: The Energy Transition Will Create 1,000 Unicorns "It is my belief that the next 1,000 unicorns--companies...

read more

PAOG Announces Plans To Add New Pharmaceutical Product Developments

  Sandusky, OH, Nov. 05, 2021  -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced plans to add multiple new pharmaceutical products to its development pipeline in addition to its ongoing development of its RespRx CBD pharmaceutical for the treatment of Chronic Obstructive Pulmonary Disease (COPD).   PAOG (resprx.com) The company has been conducting an in-depth review of its current RespRx CBD pharmaceutical development project with its CRO partner, industry...

read more

PAOG Targets First Acquisition By Year End To Accelerate 2022 Revenue Growth

  Sandusky, OH, Oct. 26, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s merger and acquisition development pipeline supports plans for a first acquisition to close before the end of this year.  PAOG is actively exploring merger and acquisition opportunities targeted at expanding the company’s product line and accelerating revenue growth. The company recently announced initiating production on its first line of CBD nutraceuticals and being on track...

read more

PAOG Announces CBD “RX” Brand Introducing Second CBD Product

  Sandusky, OH, Oct. 21, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the launch of its second CBD nutraceutical product, RehabRX CBD, in a line of coming CBD products under the PAOG CBD “RX” brand name. RehabRX is a rich formulation with beneficial botanicals proven to support healthy skin. RehabRX is free from any preservatives, colors or flavorings. The CBD comes from hemp grown in the state of Colorado.  It is Gluten-free and Non-GMO. PAOG has shipped its...

read more

PAOG Reveals CBD Products Under Development For $100 Billion Pet Market

  Sandusky, OH, Oct. 20, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today revealed the company has been working on the development of CBD products for pets and could have its first product ready to introduce before the end of the year. The pet products market is estimated at over $100 billion per year. Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No....

read more

PAOG Scheduled To Launch 2nd CBD Nutraceutical Product This Thursday

  Sandusky, OH, Oct. 19, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) yesterday announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. The company plans to launch its second CBD nutraceutical product on Thursday this week, October 21st, 2021. PAOG is on track to realize its first revenue this year, starting in Q4 2021, since the company acquired intellectual property derived through research into CBD extracted in association with a patented...

read more

PAOG To Launch Second CBD Nutraceutical Product Later This Week Further Ramping Up 2021 Revenue Potential

  Sandusky, OH, Oct. 18, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) earlier today announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. The company plans to launch its second CBD nutraceutical product later this week, On Thursday, October 21st, 2021. PAOG is on track to realize its first revenue this year, starting in Q4 2021, since the company acquired intellectual property derived through research into CBD extracted in association with a...

read more

PAOG Introduces RelaxRX CBD Targeting $100 Billion Sleep Aid Market

    Sandusky, OH, Oct. 18, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. RelaxRX is available in 30mg Softgels and in an 1800mg Tincture.  The CBD oil is 100% derived from full spectrum whole-plant hemp oil and contains no added chemicals. The sleep aid market was projected at USD 64.29 Billion in 2019 and is forecast to hit USD 101.7 Billion in 2026. PAOG has confirmed shipping...

read more

PAOG Announces Market Launch Of First CBD Nutraceutical To Take Place On Monday October 18th

  Sandusky, OH, Oct. 14, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the market launch of its first CBD Nutraceutical is scheduled to take place on Monday, October 18th, 2021. PAOG expects to realize its first CBD nutraceutical product sales beginning imminently in Q4, 2021. The company confirms shipping its first CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (OTC Pink: USMJ). PAOG plans to announce specifics...

read more

PAOG CBD Pharmaceutical Respiratory Treatment Research Garners New Interest

  Sandusky, OH, Oct. 13, 2021 -- McapMediaWire --  PAO Group, Inc. (OTC Pink: PAOG) today announced encountering a flurry of outside interest of late into the company’s CBD pharmaceutical respiratory treatment research.     Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). The ongoing research targets the treatment of respiratory disorders in support of a...

read more

PAOG Set To Realize First CBD Nutraceutical Sales In Q4 With Rapid Revenue Growth Expected To Follow

  Sandusky, OH, Oct. 11, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to realize its first CBD nutraceutical product sales beginning imminently in Q4, 2021. The company confirms shipping its first CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (OTC Pink: USMJ). PAOG plans to announce specifics about its first CBD nutraceutical product in an upcoming formal product launch announcement once the...

read more

PAOG Targets Expansion And Accelerated Revenue Growth Through M&A To Complement Existing CBD Business

  Sandusky, OH, Oct. 04, 2021 -- McapMediaWire --  PAO Group, Inc. (OTC PINK: PAOG) today announced the company is actively exploring merger and acquisition opportunities targeted at expanding the company’s product line and accelerating revenue growth. The company recently announced initiating production on its first line of CBD nutraceuticals and being on track to generate its first revenue this year, in 2021, since entering the CBD market sector. PAOG is developing CBD pharmaceutical...

read more

PURA Previews Farmersville Hemp Brand Plan For Rapid Revenue Growth

  DALLAS, TX, Oct. 04, 2021 -- McapMediaWire --  Puration, Inc. (OTC PINK: PURA) (“PURA”) today announced the company’s hemp industry-wide strategic initiative to collectively market for multiple hemp growers and processors under a single brand name - Farmersville Hemp – includes plans to provide hemp growers and processors with financing. PURA is building processing and cultivation partners with the intention of establishing an industrial hemp brand cooperative under the Farmersville...

read more

PAOG On Track To Begin Generating Revenue This Year From CBD Nutraceutical Sales

  Sandusky, OH, Sept. 30, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company has initiated production on its first line of CBD nutraceuticals and is on track to generate its first revenue this year, in 2021, since entering the CBD market sector. PAOG is developing CBD pharmaceutical and nutraceuticals from its intellectual property associated with a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR...

read more

PAOG Partners With PURA On Farmersville Hemp Brand Initiative

  Sandusky, OH, Sept. 24, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s partnership with Puration, Inc. (OTC Pink: PURA). PAOG is developing CBD pharmaceutical and nutraceuticals from its intellectual property associated with a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT." PAOG recently announced plans to launch a CBD...

read more

PAOG Confirms Plans For First CBD Nutraceutical Revenue In 2021 Targeting $16 Billion Market

  Sandusky, OH, Sept. 17, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today published a brief status update on the company’s ongoing initiatives to include confirming plans to launch a CBD Nutraceuticals line of products expected to generate revenue this year, in 2021. The company also continues in the long-term CBD pharmaceutical. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion, and it is expected to reach $16.4 Billion by 2027. PAOG plans to...

read more

PAOG Targets $18 Billion Market Opportunity With New CBD Nutraceutical To Be Packaged By ALKM And Marketed By USMJ

  Sandusky, OH, June 24, 2021 – McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today published a CBD Nutraceuticals Business Development Update. PAOG expects to generate revenue this year from its CBD Nutraceuticals. PAOG’s CBD Nutraceuticals Business Development initiative is a complementary effort running in parallel to PAOG’s ongoing Pharmaceutical Developments. PAOG is working on the development of a CBD pharmaceutical product under the name RespRx, for the treatment of Chronic...

read more

PAOG Confirms CBD Nutraceuticals Business Development Update To Include ALKM, USMJ and PURA Highlights Scheduled This Wednesday, June 23rd

  Sandusky, OH, June 21, 2021 – McapMediaWire --  PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceuticals Business Development Update scheduled for release this week, on Wednesday, June 23rd, 2021. PAOG plans to launch a CBD Nutraceuticals line of products expected to generate revenue this year, in 2021, is on track.  The company also continues in the long-term CBD pharmaceutical. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to...

read more

PAOG CBD Nutraceuticals Rollout On Track Targeting $5 Billon Market

  Sandusky, OH, June 17, 2021 –  McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed the company’s plan to launch a CBD Nutraceuticals line of products expected to generate revenue this year, in 2021, is on track.  The company also continues in the long-term CBD pharmaceutical. Next week, on Wednesday, June 23rd, management will release an update on the company’s CBD Nutraceuticals development initiative to include new developments expected to expand PAOG’s overall market...

read more

SIBANNAC, INC. LAUNCHES THE CAMPUS CO. PLATFORM

  Scottsdale, Arizona, May 11, 2021 - - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following: Sibannac, Inc. is pleased to announce the public launch of the Campus Co., a community for start-up and emerging brands in the solutions and lifestyle category. The Campus Community will serve as the portal for all consumer and commercial relationships of Sibannac moving forward.  In addition to developing revenues through contract manufacturing, the...

read more

PAOG Releases CBD Nutraceutical 2021 Product Launch Preview Highlighting PURA EVERx Partnership, ALKM Co-Packing and USMJ Distribution

  Sandusky, OH, May 7, 2021 – -- PAO Group, Inc. (OTC Pink: PAOG) today released a preview of the company’s plan to launch a CBD Nutraceuticals line of products.  PAOG’s CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments. PAOG is working on the development of a CBD pharmaceutical product under the name RespRx, for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) derived from a...

read more

PAOG Announces Save The Date For CBD Nutraceuticals Expansion Update

  Sandusky, OH, March 10, 2021 – -- PAO Group, Inc. (OTC Pink: PAOG) today encouraged all interested to save the date, Tuesday, March 16, 2021, when PAOG will publish details on the company’s CBD RELAX-RX nutraceutical development plans including intended co-packing with Alkame Holdings, Inc. (OTC Pink: ALKM) and marketing with North American Cannabis Holdings, Inc. (OTC Pink: USMJ). CBD RELAX-RX targets the anxiety and depression treatment market anticipated to reach a value of $18...

read more

PAOG To Expand Revenue Base Introducing New CBD Nutraceuticals Targeting $3.8 Billion Market

  Sandusky, Ohio, February 4, 2021 - - PAO Group, Inc. (OTC Pink: PAOG) today revealed plans to expand its nutraceutical product reach. The company plans to produce nutraceuticals for additional applications beyond the current focus on care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD). Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »